Literature DB >> 151618

Acute hypersensitivity pneumonitis associated with carbamazepine therapy.

W C Stephan, R D Parks, B Tempest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 151618     DOI: 10.1378/chest.74.4.463

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale.

Authors:  Marina Avner; Yaron Finkelstein; Dan Hackam; Gideon Koren
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 2.  Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management.

Authors:  Alberto Verrotti; Daniela Trotta; Carmela Salladini; Francesco Chiarelli
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

4.  Extensive carbamazepine eruption with eosinophilia and pulmonary infiltrate.

Authors:  N H Cox; S R Johnston; J Marks; D Bates
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

Review 5.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

6.  Pulmonary eosinophilia associated with carbamazepine.

Authors:  J Tolmie; C R Steer; A T Edmunds
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

7.  Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.

Authors:  M Pirmohamed; A Graham; P Roberts; D Smith; D Chadwick; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.